Sequana Medical N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SEQUA.BR research report →
About the company
Sequana Medical N. V. is a medical technology company that has reached the commercial stage, dedicated to creating innovative solutions for managing excessive fluid accumulation linked to liver conditions, malignant ascites, and heart failure.
- CEO
- Ian Crosbie
- IPO
- 2019
- Employees
- 48
- HQ
- Gent, BE
Price Chart
- Market Cap
- $47.76M
- P/E
- -0.47
- P/S
- 0.00
- P/B
- -0.60
- EV/EBITDA
- -5.95
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 124.12%
- ROIC
- -536.50%
- Revenue
- $106.00K · -85.12%
- Net Income
- $-44,654,000 · -37.13%
- EPS
- $-1.22 · 0.00%
- Op Income
- $-18,706,000
- FCF YoY
- 31.10%
- 52W High
- $1.62
- 52W Low
- $0.46
- 50D MA
- $0.55
- 200D MA
- $0.67
- Beta
- -0.29
- Avg Volume
- 151.14K
Get TickerSpark's AI analysis on SEQUA.BR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SEQUA.BR coverage
Recent articles, reports, and earnings notes.
No research on SEQUA.BR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SEQUA.BR report →Similar companies
Peers in the same neighborhood.